Daniel I. Pavlic
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Australian Rotavirus Surveillance Program: Annual Report, 2024.
Journal: Communicable diseases intelligence (2018)
Published: October 21, 2025
Australian Rotavirus Surveillance Program Annual Report, 2023.
Journal: Communicable diseases intelligence (2018)
Published: May 18, 2025
Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in Malawi.
Journal: Viruses
Published: August 16, 2024
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BB.
Journal: Nature communications
Published: May 02, 2024
Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status.
Journal: The Journal of infectious diseases
Published: April 18, 2023
Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.
Journal: The Lancet. Infectious diseases
Published: June 01, 2021
Rotavirus specific maternal antibodies and immune response to RV3-BB rotavirus vaccine in central java and yogyakarta, Indonesia.
Journal: Vaccine
Published: August 27, 2019
Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.
Journal: Human vaccines & immunotherapeutics
Published: April 25, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
Journal: The New England journal of medicine
Published: February 22, 2018
Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.
Journal: Human vaccines & immunotherapeutics
Published: January 07, 2017
Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: August 24, 2015
TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be rescued by wild-type bone marrow.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: October 18, 2014
Last Updated: 09/26/2026